{"title":"[Evaluation of the results of treatment of endodermal sinus tumor in children].","authors":"W Woźniak","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Endodermal sinus tumor is a rare kind of cancer in children. In Clinical Department of Pediatric Oncology there were treated 8 children with endodermal sinus tumor (EST). 4 of them were localised in sacrococcygeal region, 3 in genital system and 1 in testis. In all these cases high level of AFP was observed. Complex therapy was done including surgery, chemotherapy and rtg-therapy, giving as result 3 years survival in 1 only case. Another case is still in course of the treatment. Unified protocol of therapy is not founded till now and prognosis in majority of children is not satisfied.</p>","PeriodicalId":76348,"journal":{"name":"Problemy medycyny wieku rozwojowego","volume":"13 ","pages":"134-8"},"PeriodicalIF":0.0000,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Problemy medycyny wieku rozwojowego","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Endodermal sinus tumor is a rare kind of cancer in children. In Clinical Department of Pediatric Oncology there were treated 8 children with endodermal sinus tumor (EST). 4 of them were localised in sacrococcygeal region, 3 in genital system and 1 in testis. In all these cases high level of AFP was observed. Complex therapy was done including surgery, chemotherapy and rtg-therapy, giving as result 3 years survival in 1 only case. Another case is still in course of the treatment. Unified protocol of therapy is not founded till now and prognosis in majority of children is not satisfied.
分享
京公网安备 11010802042870号
京ICP备2023020795号-1
求助内容：
应助结果提醒方式：
扫码关注我们
